About Oxsed
Oxsed is a company based in United Kingdom founded in 2020 by Zhanfeng Cui was acquired by Prenetics in October 2020. The company has 9 employees. Oxsed operates in a competitive market with competitors including Prenetics, OpGen, Day Zero Diagnostics, Clear Labs and Karius, among others.
Investors in Oxsed
Oxsed has secured backing from 1 investor. Prominent investors backing the company include Prenetics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Health risks are identified through online genetic and diagnostic testing. | 2009 | prenetics.com | Hong Kong, China |
Investor details for Oxsed
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Oxsed
1 people are tracked at Oxsed (1 in leadership); the tracked headcount is 9.
| Name | Role | Group |
|---|---|---|
Zhanfeng Cui | Co-Founder | Leadership |
Complete people profiles for Oxsed
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Oxsed
2 dated milestones of Oxsed, from founding to its latest funding, stage changes and deals.
- Founded Oxsed is founded.
- Exit Acquired by Prenetics.
Competitors of Oxsed
Oxsed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, OpGen, Day Zero Diagnostics, Clear Labs and Karius, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| prenetics.com | 2009 | Hong Kong, China | $67.65M | – | Health risks are identified through online genetic and diagnostic testing. | |
| opgen.com | 2002 | Rockville, United States | $77.51M | 100 | Developer of diagnostics and bioinformatics platforms for providers | |
| dayzerodiagnostics.com | 2016 | Boston, United States | $48.6M | 48 | Genome sequencing diagnostics for infectious diseases are developed. | |
| clearlabs.com | 2014 | Menlo Park, United States | $171.09M | 55 | Food safety technologies are provided for pathogen identification. | |
| kariusdx.com | 2014 | Redwood, United States | $315M | 139 | Developer of a non-invasive pathogen blood test for the detection of infectious diseases | |
| alveotechnologies.com | 2014 | Alameda, United States | $63.61M | – | Cloud-powered POC MDx device | |
| curetis.com | 2007 | Holzgerlingen, Germany | $127.14M | 55 | Molecular diagnostics platform is provided for infectious disease detection. | |
| seegene.com | 2000 | Seoul, South Korea | – | – | Developer of molecular diagnostic kits to detect infectious and genetic diseases | |
| springbankpharm.com | 2002 | Milford, United States | $36.7M | 84 | Viral infection treatments are developed using nucleic acid hybrid chemistry. |
Detailed competitors of Oxsed
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oxsed
Complete news archive for Oxsed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Oxsed
10 companies that operate in the same segment as Oxsed (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Oxsed
Oxsed was founded in 2020.
Oxsed is headquartered in United Kingdom.
Oxsed has 9 employees.
Oxsed was founded in 2020 in the United Kingdom within the diagnostics sector. A flagship rapid diagnostic assay, the Oxsed RaViD Direct SARS-CoV-2 Test, is offered for detecting SARS-CoV-2 infections. Nasopharyngeal swabs, saliva, and mouthwash specimens are utilized as samples. Reverse transcription loop-mediated isothermal amplification (RT-LAMP) is employed to identify viral RNA through nucleic acid amplification testing (NAAT). Operations focus on point-of-care testing for respiratory infections.
Oxsed's top competitors include Prenetics, Clear Labs and Day Zero Diagnostics.
Oxsed has 1 investor. Key investors include Prenetics.
Oxsed operates through Oxsed Limited.
Yes. Oxsed was acquired by Prenetics in October 2020.